Patients whose tumors expressed high levels of XIAP generally had a poorer prognosis than those patients whose tumors expressed low levels of XIAP in pre-chemotherapy's cancer tissue (overall survival P = 0.025, Log Rank test, Figure 2). The gene discussed is XIAP; the disease is cancer.